Karen L. Zaderej, Director at EyePoint Pharmaceuticals, Inc. (EYPT), bought 12,500 shares at $7.98 ($100K) on 2024-08-19, disclosed to the SEC on 2024-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EYPT | BUY | 2025-05-15 | $54K | — | Filing → |
| AXGN | SELL | 2024-03-25 | $555K | — | Filing → |
| AXGN | SELL | 2021-08-10 | $1.5M | — | Filing → |